All In MedTech

Device Trial Radar · NCT07079774

TrueLok Elevate PMCF Study

Post-Market Clinical Follow-up Study of the TrueLok Elevate Transverse Bone Transport System for the Treatment of Lower Limb Ulcers as Soft Tissue Defects

Last checked: Nov 20, 2026Latest source record: Sep 4, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

153

Planned (sponsor's estimate)

Start

Nov 24, 2025

Primary completion

Nov 24, 2028

Study completion Nov 24, 2028

Sponsor

Lead sponsor
Orthofix s.r.l.Public (OFIX)
Sponsor type
Industry
First posted
Jul 23, 2025

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The TrueLok Elevate Transverse Bone Transport System is a modular external fixation device designed for transverse bone transport. It promotes local vascular and wound healing through controlled corticotomy and gradual distraction. The system is intended for adult patients with bony and/or soft tissuedefects.

Conditions

  • Wound of Skin
  • Ulcers
  • Soft Tissue Defect

Interventions

  • Transverse Bone Transport SystemDevice

    This is a prospective, international, multicentre, observational post-market clinical follow-up (PMCF) study. Adult subjects will be treated according to the manufacturer's Instructions for Use, with follow-up extending to 12 months post-device removal. Participating sites include centres in the US, Europe, the UK, and South Africa. Subjects will be followed using a phased framework: T0: Index Surgery (baseline data, operative details, ulcer status) T1: End of Distraction (device parameters, adverse events, ulcer status) T2: End of Compression (similar to T1) T3: Device Removal (confirmation of union, ulcer status) Post-removal visits: F3: 3 months F6: 6 months F12: 12 months

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Complete ulcer healingTime frame: 12 months

Locations

14 sites in 6 countries. Site status is shown where the registry gives one.

  • Universitätsklinikum Halle

    Halle, Germany · Not yet recruiting

13 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.